查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
乾眼症治療市場規模、份額和趨勢分析報告：按類型（蒸汽、房水缺乏）、按產品、按配方、按銷售渠道、按分銷渠道、按地區、按細分市場、2022 ～2030 年預測
市場調查報告書
商品編碼
1122235

乾眼症治療市場規模、份額和趨勢分析報告：按類型（蒸汽、房水缺乏）、按產品、按配方、按銷售渠道、按分銷渠道、按地區、按細分市場、2022 ～2030 年預測

Dry Eye Syndrome Treatment Market Size, Share & Trends Analysis Report By Type (Evaporative, Aqueous Deficient), By Drug, By Product, By Dosage Form, By Sales Channel, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

乾眼症治療市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球乾眼症治療市場規模預計將達到 74.3 億美元，從 2022 年到 2030 年，複合年增長率為 4.31%。市場增長歸因於屏幕使用量增加、老年人口增加和眼病患病率上升等因素。

屏幕設備的使用增加、計算機使用的迅速增加以及眨眼次數的減少正在促進蒸發性乾眼症世界的發展。例如，根據 2021 Frontiers Journal，與大流行前相比，在 COVID-19 大流行期間，成年人的屏幕使用量增加了 60-80%。觸摸屏幕可減少 66% 的眨眼次數，這會加速眼淚的蒸發，導致眼睛乾澀。

由於處方藥滲透率極低，OTC 藥物在市場上占主導地位。例如，只有 10% 的被診斷患有乾眼症的人接受過處方治療，而 75% 的人從未接受過處方治療。然而，被診斷患有乾眼症的患者人數佔所有眼科醫生的 5-35%。

此外，Xiidra 和 Restasis 等現有產品存在需要數月或數週才能顯示結果的問題。眼科醫生還表示，這些產品存在耐受性問題，失敗率高達 50%。這表明市場需求未得到滿足，預計將為計劃在未來幾年推出的管道產品創造有利可圖的機會。此外，與藥品相關的法規進一步阻礙了整個市場的增長。例如，2020 年，在監管機構對 Xiidra 的使用提出重大反對後，Novartis不得不主動撤回其在歐洲的使用。

主要參與者的創新和戰略舉措正在推動市場。新品發布是玩家常用的策略。例如，2021 年 10 月，Oyster Point Pharma 的 Tyrvaya（伐尼克蘭溶液）鼻噴霧劑被 FDA 批准為替代治療方法。

乾眼症治療市場報告亮點

按類型劃分，由於患病率增加和篩查時間增加，蒸發過強型乾眼症在 2021 年佔最大份額

按劑型來看，眼藥水在 2021 年的銷售額中佔最大份額，因為它們的可用性和對眼藥水的偏好日益增加。

按藥物劃分，作為治療乾眼症的處方藥採用率較高的 Restasis 將在 2021 年佔據最大的市場份額

從銷售渠道來看，越來越多的消費者因為便利性而選擇在線藥店，預計在線藥店將在預測期內以最快的速度增長。

2021年北美的市場規模將非常大，因為它的高患病率、高認知度和高治療率。

目錄

第一章 調查方法和範圍

  • 市場細分
    • 段範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 第一次調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法一：商品流動方法
      • 方法 2：使用自下而上的方法進行國別市場估算
      • 方法 3：使用自上而下的方法進行國別市場估算
  • 全球市場：複合年增長率計算
  • 調查假設
  • 市場份額計算
  • 二級信息列表
  • 目的
  • 縮略語表

第二章執行摘要

  • 市場概況

3. 乾眼症治療市場——行業展望

  • 市場系列展望
    • 母市場譜系展望
    • 相關/子公司市場展望
  • 繪製滲透率和增長前景
  • 市場動態
    • 市場驅動力
      • 老年人口不斷增長
      • 眼部相關疾病的患病率增加
      • 對乾眼症的認識越來越高
      • 增加隱形眼鏡的使用
    • 市場約束分析
      • 缺乏熟練的眼科醫生
  • SWOT 分析，按因素（政治和法律、經濟和技術）
  • 行業分析——波特五力
  • 監管場景
  • 重大交易和戰略聯盟
    • 新產品發布
    • 獲得
    • 擴張
    • 合夥

4 乾眼症治療市場：競爭分析

  • 主要市場參與者的最新發展和影響分析
    • 安索夫矩陣`
  • 公司分類
    • 創新者
      • 市場差異化因素
  • 供應商情況
    • 主要經銷商及渠道合作夥伴名單
    • 主要客戶
    • 2021 年主要參與者的市場份額分析
  • 上市公司
    • 競爭儀錶盤分析
  • 民營企業
    • 主要初創企業名單
  • 區域網絡圖
  • 主要區域/本地競爭對手

第 5 章乾眼症治療市場分析：Typescope，2018-2030 年（收入，百萬美元）

  • 乾眼症治療市場：類型的變異分析
  • 蒸發過強型乾眼症
  • 房水缺乏乾眼症

第 6 章乾眼症治療市場分析：藥物範圍，2018-2030 年（收入，百萬美元）

  • 乾眼症治療市場：藥物變異分析
  • Restasis
  • Xiidra
  • Cequa
  • Eysuvis
  • Tyrvaya
  • 其他

第 7 章乾眼症治療市場分析：產品範圍，2018-2030 年（收入，百萬美元）

  • 乾眼症治療市場：產品變異分析
  • 環孢素
  • 外用皮質類固醇
  • 人工淚液
  • 淚管塞
    • 可拆卸的
    • 熔化
  • 口服歐米茄補充劑
  • 其他

8 乾眼症治療市場分析：劑型範圍，2018-2030 年（收入，百萬美元）

  • 乾眼症治療市場：配方變化分析
  • 凝膠
  • 眼藥水
  • 膠囊/片劑
  • 眼藥水
  • 軟膏

第 9 章乾眼症治療市場分析：2018-2030 年分銷渠道範圍（收入，百萬美元）

  • 乾眼症治療市場：市場波動分析
  • 處方
  • 場外交易

第 10 章乾眼症治療市場分析：分銷渠道範圍，2018-2030 年（收入，百萬美元）

  • 乾眼症治療市場：分銷渠道的變化分析
  • 醫院藥房
  • 網上藥店
  • 零售藥店

第 11 章乾眼症治療市場分析，區域範圍，2018-2030，（收入，百萬美元）

  • 2021 年和 2030 年按國家/地區分列的市場份額分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 意大利
      • 西班牙
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 澳大利亞
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中東和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

12 乾眼症治療市場：公司概況

  • 公司簡介
    • Novartis AG
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • AbbVie, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Sun Pharmaceutical Industries Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Santen Pharmaceutical Co., Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • AFT Pharmaceuticals
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Johnson & Johnson Services, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Otsuka Pharmaceutical Co., Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • OASIS Medical.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Oyster Point Pharma, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Bausch & Lomb
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-974-4

Dry Eye Syndrome Treatment Market Growth & Trends:

The global dry eye syndrome treatment market size is expected to reach USD 7.43 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.31% from 2022 to 2030. The growth of the market is attributed to factors such as the increasing use of screens, the rising geriatric population, and a heightened prevalence of eye diseases.

The heightened use of devices with a screen, surging use of computers, and a decreased number of blinks are subsequently leading to the growth of evaporative dry eye syndrome globally. For instance, as per Frontiers Journal in 2021, when compared to pre-pandemic years, the use of screens has increased by 60-80% in adults during the COVID-19 pandemic. The exposure to the screen leads to a 66% decreased blinking rate, thus escalating the evaporation of tears and leading to dry eye disease.

Over-the-counter (OTC) products predominate the marketplace due to the extremely low acceptance of prescription products. For instance, only 10% of the diagnosed population is on prescription therapies, while 75% of the population has never tried prescription therapy. However, the number of patients diagnosed with dry eye syndrome accounts for 5-35% of overall ophthalmologist visits.

Moreover, existing products such as Xiidra and Restasis take months or weeks to demonstrate effects. In addition, as per eye consultants, these products have tolerability issues and a failure rate of as high as 50%. This depicts an unmet need in the market and is anticipated to create a lucrative opportunity for pipeline products expected to launch in the upcoming years. Moreover, regulations associated with the drugs further hamper the growth of the overall market. For instance, in 2020, Novartis had to voluntarily withdraw the use of Xiidra in Europe after regulators raised major objections to its use of xiidra.

Innovations and strategic initiatives by key players are driving the market. New product launch is a common strategy being used by the players. For instance, in October 2021, Tyrvaya (varenicline solution) nasal spray by Oyster Point Pharma was approved by the FDA as an alternative treatment approach.

Dry Eye Syndrome Treatment Market Report Highlights:

  • By type, evaporative dry eye syndrome held the largest share in 2021 owing to the increasing prevalence of the condition and heightened screen time
  • Based on dosage form, eye drops held the largest revenue share in 2021 owing to easy availability as well as increased preference for eye drop administration of the product
  • By drug, Restasis held the largest market share in 2021 owing to its high adoption as a prescription drug for dry eye treatment
  • Based on distribution channel, online pharmacies are expected to grow at the fastest rate over the forecast period due to the increased consumer preference for online pharmacies owing to the convenience
  • North America dominated the market in 2021 due to the high prevalence of the disease, surging awareness, and enhanced treatment rate

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
      • 1.6.1.3 Approach 3: Country-wise market estimation using top-down approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 Market Share Calculations
  • 1.10 List of Secondary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
  • 1.12 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Dry Eye Syndrome Treatment Market - Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Growing geriatric population
      • 3.3.1.2 Increasing prevalence of eye-related diseases
      • 3.3.1.3 Growth in awareness of dry eye syndrome
      • 3.3.1.4 Increasing use of contact lenses
    • 3.3.2 Market restraint Analysis
      • 3.3.2.1 Lack of skilled ophthalmologists
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's Five Forces
  • 3.6 Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships

Chapter 4 Dry Eye Syndrome Treatment Market: Competitive Analysis

  • 4.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 4.1.1 Ansoff matrix`
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
    • 4.3.3 Key company market share analysis, 2021
  • 4.4 Public Companies
    • 4.4.1 Competitive dashboard analysis
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies
  • 4.6 Regional Network Map
  • 4.7 Key Regional/Local Competitors

Chapter 5 Dry Eye Syndrome Treatment Market Analysis: Type Scope, 2018 - 2030 (Revenue, USD Million)

  • 5.1 Dry Eye Syndrome Treatment Market: Type Movement Analysis
  • 5.2 Evaporative Dry Eye Syndrome
    • 5.2.1 Evaporative dry eye syndrome market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3 Aqueous Deficient Dry Eye Syndrome
    • 5.3.1 Aqueous deficient dry eye syndrome market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Dry Eye Syndrome Treatment Market Analysis: Drug Scope, 2018 - 2030 (Revenue, USD Million)

  • 6.1 Dry Eye Syndrome Treatment Market: Drug Movement Analysis
  • 6.2 Restasis
    • 6.2.1 Restasis market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3 Xiidra
    • 6.3.1 Xiidra market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4 Cequa
    • 6.4.1 Cequa market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5 Eysuvis
    • 6.5.1 Eysuvis market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6 Tyrvaya
    • 6.6.1 Tyrvaya market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7 Others
    • 6.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Dry Eye Syndrome Treatment Market Analysis: Product Scope, 2018 - 2030 (Revenue, USD Million)

  • 7.1 Dry Eye Syndrome Treatment Market: Product Movement Analysis
  • 7.2 Cyclosporine
    • 7.2.1 Cyclosporine market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3 Topical Corticosteroids
    • 7.3.1 Topical Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4 Artificial Tears
    • 7.4.1 Artificial Tears market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5 Punctal Plugs
    • 7.5.1 Punctal Plugs market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2 Removable
      • 7.5.2.1 Removable market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3 Dissolvable
      • 7.5.3.1 Dissolvable market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6 Oral Omega Supplements
    • 7.6.1 Oral Omega Supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7 Others
    • 7.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Dry Eye Syndrome Treatment Market Analysis: Dosage Form Scope, 2018 - 2030 (Revenue, USD Million)

  • 8.1 Dry Eye Syndrome Treatment Market: Dosage Form Movement Analysis
  • 8.2 Gels
    • 8.2.1 Gels market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3 Eye Solution
    • 8.3.1 Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4 Capsules & Tablets
    • 8.4.1 Capsules & tablets market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5 Eye Drops
    • 8.5.1 Eye drops market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6 Ointments
    • 8.6.1 Ointments market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Dry Eye Syndrome Treatment Market Analysis: Sales Channel Scope, 2018 - 2030 (Revenue, USD Million)

  • 9.1 Dry Eye Syndrome Treatment Market: Sales Channel Movement Analysis
  • 9.2 Prescription
    • 9.2.1 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.3 OTC
    • 9.3.1 OTC market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10 Dry Eye Syndrome Treatment Market Analysis: Distribution Channel Scope, 2018 - 2030 (Revenue, USD Million)

  • 10.1 Dry Eye Syndrome Treatment Market: Distribution Channel Movement Analysis
  • 10.2 Hospital Pharmacies
    • 10.2.1 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 10.3 Online Pharmacies
    • 10.3.1 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 10.4 Retail Pharmacies
    • 10.4.1 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 11 Dry Eye Syndrome Treatment Market Analysis, Regional Scope, 2018 - 2030, (Revenue, USD Million)

  • 11.1 Market Share Analysis by Country, 2021 & 2030
    • 11.1.1 North America
      • 11.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.1.2 U.S.
      • 11.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.1.3 Canada
      • 11.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.2 Europe
      • 11.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.2.2 U.K.
      • 11.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.2.3 Germany
      • 11.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.2.4 France
      • 11.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.2.5 Italy
      • 11.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.2.6 Spain
      • 11.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.3 Asia Pacific
      • 11.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.3.2 Japan
      • 11.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.3.3 China
      • 11.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.3.4 India
      • 11.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.3.5 South Korea
      • 11.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.3.6 Australia
      • 11.1.3.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.4 Latin America
      • 11.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.4.2 Brazil
      • 11.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.4.3 Mexico
      • 11.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.4.4 Argentina
      • 11.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.5 Middle East and Africa
      • 11.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.5.2 South Africa
      • 11.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.5.3 Saudi Arabia
      • 11.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.5.4 UAE
      • 11.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 12 Dry Eye Syndrome Treatment Market: Company Profiling

  • 12.1 Company Profiles
    • 12.1.1 Novartis AG
      • 12.1.1.1 Company overview
      • 12.1.1.2 Financial performance
      • 12.1.1.3 Product benchmarking
      • 12.1.1.4 Strategic initiatives
    • 12.1.2 AbbVie, Inc.
      • 12.1.2.1 Company overview
      • 12.1.2.2 Financial performance
      • 12.1.2.3 Product benchmarking
      • 12.1.2.4 Strategic initiatives
    • 12.1.3 Sun Pharmaceutical Industries Ltd.
      • 12.1.3.1 Company overview
      • 12.1.3.2 Financial performance
      • 12.1.3.3 Product benchmarking
      • 12.1.3.4 Strategic initiatives
    • 12.1.4 Santen Pharmaceutical Co., Ltd.
      • 12.1.4.1 Company overview
      • 12.1.4.2 Financial performance
      • 12.1.4.3 Product benchmarking
      • 12.1.4.4 Strategic initiatives
    • 12.1.5 AFT Pharmaceuticals
      • 12.1.5.1 Company overview
      • 12.1.5.2 Financial performance
      • 12.1.5.3 Product benchmarking
      • 12.1.5.4 Strategic initiatives
    • 12.1.6 Johnson & Johnson Services, Inc.
      • 12.1.6.1 Company overview
      • 12.1.6.2 Financial performance
      • 12.1.6.3 Product benchmarking
      • 12.1.6.4 Strategic initiatives
    • 12.1.7 Otsuka Pharmaceutical Co., Ltd.
      • 12.1.7.1 Company overview
      • 12.1.7.2 Financial performance
      • 12.1.7.3 Product benchmarking
      • 12.1.7.4 Strategic initiatives
    • 12.1.8 OASIS Medical.
      • 12.1.8.1 Company overview
      • 12.1.8.2 Financial performance
      • 12.1.8.3 Product benchmarking
      • 12.1.8.4 Strategic initiatives
    • 12.1.9 Oyster Point Pharma, Inc.
      • 12.1.9.1 Company overview
      • 12.1.9.2 Financial performance
      • 12.1.9.3 Product benchmarking
      • 12.1.9.4 Strategic initiatives
    • 12.1.10 Bausch & Lomb
      • 12.1.10.1 Company overview
      • 12.1.10.2 Financial performance
      • 12.1.10.3 Product benchmarking
      • 12.1.10.4 Strategic initiatives

List of Tables

  • 1. List of Secondary Sources
  • 2. List of Abbreviations
  • 3. Incidence of Diseases
  • 4. Global Dry Eye Syndrome Treatment Market, By Region, 2018 - 2030 (USD Million)
  • 5. Global Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 6. Global Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 7. Global Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 8. Global Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 9. Global Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 10. Global Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 11. North America Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • 12. North America Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 13. North America Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 14. North America Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 15. North America Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 16. North America Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 17. North America Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 18. U.S. Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 19. U.S. Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 20. U.S. Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 21. U.S. Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 22. U.S. Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 23. U.S. Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 24. Canada Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 25. Canada Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 26. Canada Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 27. Canada Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 28. Canada Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 29. Canada Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 30. Europe Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • 31. Europe Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 32. Europe Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 33. Europe Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 34. Europe Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 35. Europe Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 36. Germany Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 37. Germany Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 38. Germany Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 39. Germany Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 40. Germany Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 41. Germany Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 42. U.K. Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 43. U.K. Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 44. U.K. Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 45. U.K. Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 46. U.K. Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 47. U.K. Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 48. France Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 49. France Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 50. France Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 51. France Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 52. France Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 53. France Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 54. Italy Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 55. Italy Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 56. Italy Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 57. Italy Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 58. Italy Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 59. Italy Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 60. Spain Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 61. Spain Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 62. Spain Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 63. Spain Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 64. Spain Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 65. Spain Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 66. Asia Pacific Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • 67. Asia Pacific Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 68. Asia Pacific Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 69. Asia Pacific Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 70. Asia Pacific Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 71. Asia Pacific Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 72. Asia Pacific Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 73. Japan Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 74. Japan Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 75. Japan Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 76. Japan Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 77. Japan Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 78. Japan Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 79. China Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 80. China Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 81. China Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 82. China Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 83. China Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 84. China Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 85. India Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 86. India Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 87. India Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 88. India Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 89. India Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 90. India Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 91. South Korea Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 92. South Korea Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 93. South Korea Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 94. South Korea Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 95. South Korea Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 96. South Korea Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 97. Australia Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 98. Australia Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 99. Australia Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 100. Australia Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 101. Australia Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 102. Australia Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 103. Latin America Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • 104. Latin America Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 105. Latin America Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 106. Latin America Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 107. Latin America Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 108. Latin America Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 109. Latin America Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 110. Brazil Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 111. Brazil Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 112. Brazil Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 113. Brazil Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 114. Brazil Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 115. Brazil Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 116. Mexico Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 117. Mexico Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 118. Mexico Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 119. Mexico Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 120. Mexico Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 121. Mexico Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 122. Argentina Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 123. Argentina Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 124. Argentina Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 125. Argentina Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 126. Argentina Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 127. Argentina Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 128. Middle East & Africa Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • 129. Middle East & Africa Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 130. Middle East & Africa Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 131. Middle East & Africa Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 132. Middle East & Africa Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 133. Middle East & Africa Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 134. Middle East & Africa Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 135. Saudi Arabia Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 136. Saudi Arabia Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 137. Saudi Arabia Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 138. Saudi Arabia Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 139. Saudi Arabia Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 140. Saudi Arabia Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 141. South Africa Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 142. South Africa Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 143. South Africa Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 144. South Africa Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 145. South Africa Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 146. South Africa Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 147. UAE Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 148. UAE Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 149. UAE Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 150. UAE Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 151. UAE Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 152. UAE Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • 1. Market Research Process
  • 2. Information Procurement
  • 3. Primary Research Pattern
  • 4. Market Research Approaches
  • 5. Value Chain-Based Sizing & Forecasting
  • 6. Market Formulation & Validation
  • 7. Dry Eye Syndrome Treatment Market Segmentation
  • 8. Market Driver Relevance Analysis (Current & Future Impact)
  • 9. Market Restraint Relevance Analysis (Current & Future Impact)
  • 10. Market Challenge Relevance Analysis (Current & Future Impact)
  • 11. Penetration & Growth Prospect Mapping
  • 12. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 13. Porter's Five Forces Analysis
  • 14. Market Penetration & Growth Prospect Mapping
  • 15. Dry eye syndrome treatment market: Type outlook and key takeaways
  • 16. Dry eye syndrome treatment market: Type movement analysis & market share 2021 & 2030
  • 17. Evaporative dry eye syndrome treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • 18. Aqueous dry eye syndrome treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • 19. Dry eye syndrome treatment market: Drug outlook and key takeaways
  • 20. Dry eye syndrome treatment market: Drug movement analysis & market share 2021 & 2030
  • 21. Restasis market estimates and forecast, 2018 - 2030 (USD Million)
  • 22. Xiidra market estimates and forecast, 2018 - 2030 (USD Million)
  • 23. Cequa market estimates and forecast, 2018 - 2030 (USD Million)
  • 24. Eysuvis market estimates and forecast, 2018 - 2030 (USD Million)
  • 25. Tyrvaya market estimates and forecast, 2018 - 2030 (USD Million)
  • 26. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • 27. Dry eye syndrome treatment market: Product outlook and key takeaways
  • 28. Dry eye syndrome treatment market: Product movement analysis & market share 2021 & 2030
  • 29. Cyclosporine market estimates and forecast, 2018 - 2030 (USD Million)
  • 30. Topical Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • 31. Artificial tears market estimates and forecast, 2018 - 2030 (USD Million)
  • 32. Punctal plugs market estimates and forecast, 2018 - 2030 (USD Million)
  • 33. Oral omega supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • 34. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • 35. Dry eye syndrome treatment market: Dosage form outlook and key takeaways
  • 36. Dry eye syndrome treatment market: Dosage form movement analysis & market share 2021 & 2030
  • 37. Gels market estimates and forecast, 2018 - 2030 (USD Million)
  • 38. Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • 39. Capsules and tablets market estimates and forecast, 2018 - 2030 (USD Million)
  • 40. Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • 41. Ointments market estimates and forecast, 2018 - 2030 (USD Million)
  • 42. Dry eye syndrome treatment market: Sales channel outlook and key takeaways
  • 43. Dry eye syndrome treatment market: Sales channel movement analysis & market share 2021 & 2030
  • 44. Prescription market estimates and forecast, 2018 - 2030 (USD Million)
  • 45. OTC market estimates and forecast, 2018 - 2030 (USD Million)
  • 46. Dry eye syndrome treatment market: Distribution channel outlook and key takeaways
  • 47. Dry eye syndrome treatment market: Distribution channel movement analysis & market share 2021 & 2030
  • 48. Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 49. Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 50. Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 51. Regional Marketplace: Key Takeaways
  • 52. Regional Outlook, 2018 & 2030
  • 53. Regional Market Dashboard
  • 54. Regional Market Place: Key Takeaways
  • 55. North America, SWOT Analysis
  • 56. Europe, SWOT Analysis
  • 57. Asia Pacific, SWOT Analysis
  • 58. Latin America, SWOT Analysis
  • 59. MEA, SWOT Analysis
  • 60. North America
  • 61. North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 62. U.S.
  • 63. U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 64. Canada
  • 65. Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 66. Europe
  • 67. Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 68. U.K.
  • 69. U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 70. Germany
  • 71. Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 72. France
  • 73. France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 74. Italy
  • 75. Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 76. Spain
  • 77. Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 78. Asia Pacific
  • 79. Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 80. Japan
  • 81. Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 82. China
  • 83. China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 84. India
  • 85. India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 86. Australia
  • 87. Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 88. South Korea
  • 89. South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 90. Latin America
  • 91. Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 92. Brazil
  • 93. Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 94. Mexico
  • 95. Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 96. Argentina
  • 97. Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 98. MEA
  • 99. MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 100. South Africa
  • 101. South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 102. Saudi Arabia
  • 103. Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 104. UAE
  • 105. UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 106. Strategy Mapping